NORI was established in 2011 by Mark Simon. Since that time, NORI has grown into a worldwide organization and network of doctors who practice the NORI Protocol. Mark Simon is an independent cancer researcher with an extensive background in science and engineering. Mark Simon is also the CEO of NORI Nutraceuticals, a manufacturer of general supplements and specialized nutraceuticals for clinical oncology. Mark Simon has personally formulated and developed all of the NORI Nutraceuticals products; this achievement was the culmination of over a decade of independent research. NORI is a leader in the field of non-toxic means of cancer management.